You conveniently left out the fact that the investment is to be in staged tranches.
For all we know the initial tranche for early stage research could be as little as $1m with the balance to potentially tipped in over 15 years of development.
All I know is Starpharma have chosen to give away their IP in exchange for a minority equity stake in a new non-listed entity controlled by others, rather than demanding a cash up front licence fee.
That’s a fact.
Outmanoeuvred IMO.
- Forums
- ASX - By Stock
- SPL
- Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-46
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.8¢ |
Change
0.002(2.08%) |
Mkt cap ! $40.90M |
Open | High | Low | Value | Volume |
9.7¢ | 9.9¢ | 9.7¢ | $65.08K | 662.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 36445 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 64440 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 36445 | 0.098 |
1 | 128722 | 0.096 |
1 | 59000 | 0.095 |
1 | 100000 | 0.093 |
1 | 49413 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 64440 | 3 |
0.100 | 101606 | 3 |
0.105 | 114641 | 4 |
0.110 | 51546 | 2 |
0.115 | 109827 | 3 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online